Inhibikase Therapeutics I... (IKT)
NASDAQ: IKT
· Real-Time Price · USD
1.74
0.03 (1.75%)
At close: Aug 15, 2025, 12:28 PM
Inhibikase Therapeutics Revenue
Inhibikase Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending March 31, 2025, Inhibikase Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
0
Employees
15
Market Cap
129.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|